Role of Genetic Testing in Inherited Cardiovascular Disease: A Review.

Allison L Cirino, Stephanie Harris, Neal K Lakdawala, Michelle Michels, Iacopo Olivotto, Sharlene M Day, Dominic J Abrams, Philippe Charron, Colleen Caleshu, Christopher Semsarian, Jodie Ingles, Harry Rakowski, Daniel P Judge, Carolyn Y Ho

Journal: JAMA cardiology 2019;2(10):1153-1160

PMID: 28793145

Abstract

IMPORTANCE

Genetic testing is a valuable tool for managing inherited cardiovascular disease in patients and families, including hypertrophic, dilated, and arrhythmogenic cardiomyopathies and inherited arrhythmias. By identifying the molecular etiology of disease, genetic testing can improve diagnostic accuracy and refine family management. However, unique features associated with genetic testing affect the interpretation and application of results and differentiate it from traditional laboratory-based diagnostics. Clinicians and patients must have accurate and realistic expectations about the yield of genetic testing and its role in management. Familiarity with the rationale, implications, benefits, and limitations of genetic testing is essential to achieve the best possible outcomes.

OBSERVATIONS

Successfully incorporating genetic testing into clinical practice requires (1) recognizing when inherited cardiovascular disease may be present, (2) identifying appropriate individuals in the family for testing, (3) selecting the appropriate genetic test, (4) understanding the complexities of result interpretation, and (5) effectively communicating the results and implications to the patient and family. Obtaining a detailed family history is critical to identify families who will benefit from genetic testing, determine the best strategy, and interpret results. Instead of focusing on an individual patient, genetic testing requires consideration of the family as a unit. Consolidation of care in centers with a high level of expertise is recommended. Clinicians without expertise in genetic testing will benefit from establishing referral or consultative networks with experienced clinicans in specialized multidisciplinary clinics.

CONCLUSIONS AND RELEVANCE

Genetic testing provides a foundation for transitioning to more precise and individualized management. By distinguishing phenotypic subgroups, identifying disease mechanisms, and focusing family care, gene-based diagnosis can improve management. Successful integration of genetic testing into clinical practice requires understanding of the complexities of testing and effective communication of the implications to patients and families.

Address: Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Cardiology, The Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.; Referral Centre for Myocardial Diseases, Careggi University Hospital, Florence, Italy.; Cardiovascular Division, Department of Internal Medicine, University of Michigan, Ann Arbor.; Inherited Cardiac Arrhythmia Program, Division of Cardiac Electrophysiology, Boston Children's Hospital, Boston, Massachusetts.; Referral Center for Cardiac Hereditary Diseases, Assistance Publique-Hôpitaux de Paris, Institute of Cardiometabolism and Nutrition, Hôpital de la Pitié-Salpêtrière, Paris, France.; Stanford Center for Inherited Cardiovascular Disease, Stanford, California.; Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, University of Sydney, Sydney, Australia.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Cardiology, Johns Hopkins University, Baltimore, Maryland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.